CymaBay Therapeutics
CBAY
$32.48
Share price
0.00%
Change (1 day)
221.27%
Change (1 year)
Categories
CymaBay Therapeutics (CBAY) - Total assets
Total assets on the balance sheet as of December 2023 : $0.43 B
According to CymaBay Therapeutics 's latest financial reports the company's total assets are $0.43 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
CymaBay Therapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.43 B | 206.44% |
| 2022-12-31 | $0.14 B | -29.89% |
| 2021-12-31 | $0.20 B | 31.52% |
| 2020-12-31 | $0.15 B | -25.23% |
| 2019-12-31 | $0.20 B | 10.16% |
| 2018-12-31 | $0.18 B | 79.14% |
| 2017-12-31 | $0.10 B | 438.49% |
| 2016-12-31 | $19.35 M | -55.06% |
| 2015-12-31 | $43.07 M | 14.96% |
| 2014-12-31 | $37.47 M | 15.3% |
| 2013-12-31 | $32.5 M | 300.44% |
| 2012-12-31 | $8.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 52,006.81% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 22,682.19% | 🇺🇸 USA |
 Xencor XNCR | $0.95 B | 119.17% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $1.89 B | 336.11% | 🇺🇸 USA |